0001209191-15-065926.txt : 20150813 0001209191-15-065926.hdr.sgml : 20150813 20150813202050 ACCESSION NUMBER: 0001209191-15-065926 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150811 FILED AS OF DATE: 20150813 DATE AS OF CHANGE: 20150813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 BUSINESS PHONE: 604-629-9223 MAIL ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mitchell David Chilton CENTRAL INDEX KEY: 0001627684 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 151052251 MAIL ADDRESS: STREET 1: C/O AQUINOX PHARMACEUTICALS, INC. STREET 2: 450 - 887 GREAT NORTHERN WAY CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-11 0 0001404644 AQUINOX PHARMACEUTICALS, INC AQXP 0001627684 Mitchell David Chilton C/O AQUINOX PHARMACEUTICALS, INC. 450 - 887 GREAT NORTHERN WAY VANCOUVER A1 V5T 4T5 BRITISH COLUMBIA, CANADA 0 1 0 0 VP Global Regulatory & Quality Common Stock 2015-08-11 4 P 0 1600 24.36 A 1600 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.255 to $24.47. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote. /s/ David C. Mitchell 2015-08-13